Charming Medical Ltd

Charming Medical Ltd(MCTA)股票分析

$29.355

+1.981 (+6.75%)收盘时

Loading chart…
High
31.700
Open
28.350
VWAP
28.98
Vol
4.25M
Mkt Cap
Low
25.900
Amount
123.23M
EV/EBITDA, TTM
0.00

Charming Medical Ltd is a holding company principally engaged in the provision of beauty, wellness and postpartum services. The Company is principally engaged in the provision of beauty, wellness and postpartum services using traditional Chinese medicines approaches, includes womb-warming therapy, beauty, tailor-made, slim (BTS) pelvic detox therapy, agarwood moxibustion treatment, traditional Chinese medicine (TCM)-inspired prenatal massages as well as others. The Company is also engaged in the sale of TCM-inspired supplements products such as home herbal uterine care patches, probiotic intimate wash, Yin nourishing pill sets as well as others. In addition, the Company is engaged in the provision of TCM-inspired therapy technical training, dietary therapy training and other consultancy services to other beauty salons, massage centers and similar entities.

AI analysis of Charming Medical Ltd (MCTA)

buy

Charming Medical Ltd (MCTA) appears to be a good buy right now due to its impressive recent performance and strong gross margins. The stock has seen a remarkable 633.88% increase over the past year, and its gross margin stands at an impressive 95.77% for Q4 2025. However, investors should be cautious due to a high debt-to-equity ratio of 869.28% in Q4 2025, indicating significant leverage and potential financial risk.

估值指标

The current forward P/E ratio for Charming Medical Ltd (MCTA) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
22.38
Current P/S
0.00
高估
26.38
低估
18.39

事件时间线

2025-11-26 (ET)

07:08:07

Nasdaq Suspends Trading of Charming Medical

2025-10-21 (ET)

12:00:43

Charming Medical Debuts at $4.59 After IPO Set at $4.00 per Share

11:04:01

Charming Medical Launches IPO of 1.6M Class A Ordinary Shares at $4.00 Each

2025-10-20 (ET)

12:40:18

Charming Medical Sets IPO Price Range at $4.00 to $6.00 for 1.6 Million Shares

资讯

MCTA FAQ — answered by Alphio AI

Charming Medical Ltd is a holding company principally engaged in the provision of beauty, wellness and postpartum services. The Company is principally engaged in the provision of beauty, wellness and postpartum services using traditional Chinese medicines approaches, includes womb-warming therapy, beauty, tailor-made, slim (BTS) pelvic detox therapy, agarwood moxibustion treatment, traditional Chinese medicine (TCM)-inspired prenatal massages as well as others. The Company is also engaged in the sale of TCM-inspired supplements products such as home herbal uterine care patches, probiotic intimate wash, Yin nourishing pill sets as well as others. In addition, the Company is engaged in the provision of TCM-inspired therapy technical training, dietary therapy training and other consultancy services to other beauty salons, massage centers and similar entities. It operates in the Healthcare sector.

Charming Medical Ltd (MCTA) appears to be a good buy right now due to its impressive recent performance and strong gross margins. The stock has seen a remarkable 633.88% increase over the past year, and its gross margin stands at an impressive 95.77% for Q4 2025. However, investors should be cautious due to a high debt-to-equity ratio of 869.28% in Q4 2025, indicating significant leverage and potential financial risk.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始